Genes involved in hereditary hearing impairment

Current Genomics

Volumn 4, Issue 5, 2003, Pages 379-415

  Haack, B ^a   Pfister, M ^a   Blin, N ^a   Kupka, S ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Development; Hereditary hearing impairment (HHI); Inner ear physiologogy; Ion exchange; Non syndromic; Structure; Syndromic

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CONNEXIN 26; CONNEXIN 32; CONNEXIN 43; CYTOSKELETON PROTEIN; ENDOTHELIN; ENDOTHELIN RECEPTOR; GAP JUNCTION PROTEIN; ION; MYOSIN; TRANSCRIPTION FACTOR;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CHILDHOOD DISEASE; CLINICAL PRACTICE; DEVELOPMENT; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETICS; HEARING; HEARING IMPAIRMENT; HUMAN; INNER EAR; ION EXCHANGE; MITOCHONDRION; PERCEPTION DEAFNESS; PHYSIOLOGY; REVIEW; SENSORY DYSFUNCTION; SYNDROME; X CHROMOSOME LINKAGE;

EID: 0038158311     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389202033490321     Document Type: Review

References (284)

1. Morton, N.E. Genetic epidemiology of hearing impairment. Ann. N.Y. Acad.Sci., 1991, 630:16-31
2. Van Camp, G. and Smith, R.J. Hereditary hearing loss homepage, World Wide Web URL: http://dnalab-www.uia.ac.be/dnalab/hhh/.07/2002.
3. Steel, K.P. and Kros, C.J. A genetic approach to understanding auditory function. Nat. Genet., 2001, 271: 43-149.
4. Bergstrom, L., and Stewart, J. New concepts in congenital deafness. Otolaryngol. Clin. North Am., 1971, 4: 431-443.
5. Wallis, C., Ballo, R., Wallis, G., Beighton, P., Goldblatt, J. X-linked mixed deafness with stapes fixation in a Mauritian kindred: linkage to, Xq probe pDP34. Genomics, 1988, 3: 299-301.
6. Guilford, P., Ben Arab, S., Blanchard S., Levilliers, J., Weissenbach, J., Belkahia, A., Petit, C. A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat. Genet., 1994, 6: 24-28.
7. Denoyelle, F., Weil, D., Maw, M.A., Wilcox, S.A., Lench, N.J., Allen-Powell, D.R., Osborn, A.H., Dahl, H.H., Middleton, A., Houseman, M.J,. Dode, C., Marlin, S., Boulila-ElGaied, A., Grati, M., Ayadi, H., BenArab, S., Bitoun, P., Lina-Granade, G., Godet, J., Mustapha, M., Loiselet, J., El Zir, E., Aubois, A., Joannard, A., Petit, C. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum. Mol. Genet., 1997, 6: 2173-2177.
8. Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., Garabedian, E.N., Petit, C. Clinical features of the prevalent form of childhood deafness, DFNBI, due to a connexin-26 gene defect: implications for genetic counselling. Lancet, 1999, 353: 1298-1303.
9. Estivill, X., Fortina, P., Surrey, S., Rabionet, R., Melchionda, S., D'Agruma, L., Mansfield, E., Rappaport, E., Govea, N., Mila, M., Zelante, L., Gasparini, P. Connexin-26 mutations in sporadic and inherited sensorincural deafness. Lancet, 1998, 351: 394-398.
10. Kelsell, D.P., Dunlop, J., Stevens, H.P., Lench, N.J., Liang, J.N., Parry, G., Mueller, R.F., Leigh, I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature, 1997, 387: 80-83.
11. Lench, N., Houseman, M., Newton, V., Van Camp, G., Mueller, R. Connexin-26 mutations in sporadic nonsyndromal sensorineural deafness. Lancet, 1998, 351: 415.
12. Toth, T., Kupka, S., Esmer, H., Zeissler, U., Sziklai, I., Zenner, H.P., Blin, N., Pfister, M. Frequency of the recessive 30delG mutation in the GJB2 gene in Northeast-Hungarian individuals and patients with hearing impairment. Int.J. Mol. Med., 2001, 8: 189-192.
13. Kupka, S., Mirghomizadeh, F., Haug, T., Braun, S., Leistenschneider, P., Schmitz-Salue, C., Arold, R., Blin, N., Zenner, H.P., Pfister, M. Mutational analysis of the connexin26 gene in sporadic cases of moderate to profound deafness. HNO, 2000, 48: 671-674.
14. Lench, N.J., Markham, A.F., Mueller, R.F., Kelsell, D.P., Smith, R.J., Willems, P.J., Schatteman, I., Capon, H., Van De Heyning, P.J., Van Camp, G. A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2). J. Med. Genet., 1998, 35: 151-152.
15. Zelante, L., Gasparini, P., Estivill, X., Melchionda, S., D'Agruma, L., Govea, N., Mila, M., Monica, M.D., Lutfi, J., Shohat, M., Mansfield, E., Delgrosso, K., Rappaport, E., Surrey, S., Fortina, P. Connexin26 mutations associated with the most common form of non- syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum. Mol. Genet., 1997, 6: 1605-1609.
16. Denoyelle, F., Weil, D., Maw, M.A., Wilcox, S.A., Lench, N.J., Allen-Powell, D.R., Osborn, A.H., Dahl, H.H., Middleton, A., Houseman, M.J., Dode, C., Marlin, S., Boulila-ElGaied, A., Grati, M., Ayadi, H., BenArab, S., Bitoun, P., Lina-Granade, G., Godet, J., Mustapha, M., Loiselet, J., El Zir, E., Aubois, A., Joannard, A., Petit, C. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum. Mol. Genet., 1997, 6: 2173-2177.
17. Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., Garabedian, E.N., Petit, C. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet, 1999, 353: 1298-1303.
18. Estivill, X., Fortina, P., Surrey, S., Rabionet, R., Melchionda, S., D'Agruma, L., Mansfield, E., Rappaport, E., Govea, N., Mila, M., Zelante, L., Gasparini, P. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet, 1998, 351: 394-398.
19. Kelsell, D.P., Dunlop, J., Stevens, H.P., Lench, N.J., Liang, J.N., Parry, G., Mueller, R.F., Leigh, I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature, 1997, 387: 80-83.
20. Lench, N.J., Markham, A.F., Mueller, R.F., Kelsell, D.P., Smith, R.J., Willems, P.J., Schatteman, I., Capon, H., Van De Heyning, P.J., Van Camp, G. A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2). J. Med. Genet., 1998, 35: 151-152.
21. Zelante, L., Gasparini, P., Estivill, X., Melchionda, S., D'Agruma, L., Govea, N., Mila, M., Monica, M.D., Lutfi, J., Shohat, M., Mansfield, E., Delgrosso, K., Rappaport, E., Surrey, S., Fortina, P. Connexin26 mutations associated with the most common form of non- syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum. Mol. Genet., 1997, 6: 1605-1609.
22. Kelley, P.M., Harris, D.J., Comer, B.C., Askew, J.W., Fowler, T., Smith, S.D., Kimberling, W.J. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am. J. Hum. Genet., 1998, 62: 792-799.
23. Gasparini, P., Rabionet, R., Barbujani, G., Melchionda, S., Petersen, M., Brondum-Nielsen, K., Metspalu, A., Oitmaa, E., Pisano, M., Fortina, P., Zelante, L., Estivill, X. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur. J. Hum. Genet., 2000, 8: 19-23.
24. Rabionet, R., Zelante, L., Lopez-Bigas, N., D'Agruma, L., Melchionda, S., Restagno, G., Arbones, M.L., Gasparini, P., Estivill, X. Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene. Hum. Genet., 2000, 106: 40-44.
25. Murgia, A., Orzan, E., Polli, R., Martella, M., Vinanzi, C., Leonardi, E., Arslan, E., Zacchello, F. Cx26 deafness: mutation analysis and clinical variability. J. Med. Genet., 1999, 36: 829-832.
26. Fuse, Y., Doi, K., Hasegawa, T., Sugii, A., Hibino, H., Kubo, T. Three novel connexin26 gene mutations in autosomal recessive non- syndromic deafness. Neuroreport, 1999, 10: 1853-1857.
27. Abe, S., Usami, S., Shinkawa, H., Kelley, P.M., Kimberling, W.J. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J. Med. Genet., 2000, 37: 41-43.
28. Gasparini, P., Rabionet, R., Barbujani, G., Melchionda, S., Petersen, M., Brondum-Nielsen, K., Metspalu, A., Oitmaa, E., Pisano, M., Fortina, P., Zelante, L., Estivill, X. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur. J. Hum. Genet., 2000, 8: 19-23.
29. Rabionet, R., Zelante, L., Lopez-Bigas, N., D'Agruma, L., Melchionda, S., Restagno, G., Arbones, M.L., Gasparini, P., Estivill, X. Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene. Hum. Genet., 2000, 106: 40-44.
30. Murgia, A., Orzan, E., Polli, R., Martella, M., Vinanzi, C., Leonardi, E., Arslan, E., Zacchello, F. Cx26 deafness: mutation analysis and clinical variability. J. Med. Genet., 1999, 36: 829-832.
31. Fuse, Y., Doi, K., Hasegawa, T., Sugii, A., Hibino, H., Kubo, T. Three novel connexin26 gene mutations in autosomal recessive non- syndromic deafness. Neuroreport, 1999, 10: 1853-1857.
32. Abe, S., Usami, S., Shinkawa, H., Kelley, P.M., Kimberling, W.J. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J. Med. Genet., 2000, 37: 41-43.
33. Kikuchi, T., Kimura, R.S., Paul, D.L., Adams, J.C. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat. Embryol. (Berl)., 1995, 191: 101-118.
34. Kikuchi, T., Adams, J.C., Paul, D.L., Kimura, P.S. Gap junction systems in the rat vestibular labyrinth: immunohistochemical and ultrastructural analysis. Acta Otolaryngol., 1994, 114: 520-528.
35. Kikuchi, T., Kimura, R.S., Paul, D.L., Adams, J.C. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat. Embryol. (Berl)., 1995, 191: 101-118.
36. Kikuchi, T., Adams, J.C., Paul, D.L., Kimura, R.S. Gap junction systems in the rat vestibular labyrinth: immunohistochemical and ultrastructural analysis. Acta. Otolaryngol., 1994, 114: 520-528.
37. Grifa, A., Wagner, C.A., D'Ambrosio, L., Melchionda, S., Bernardi, F., Lopez-Bigas, N., Rabionet, R., Arbones, M., Monica, M.D., Estivill, X., Zelante, L., Lang, F., Gasparini, P. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat. Genet., 1999, 23: 16-18.
38. Lamartine, J., Munhoz, E.G., Kibar, Z., Lanneluc, I., Callouet, E., Laoudj, D., Lemaitre, G., Hand, C., Hayflick, S.J., Zonana, J., Antonarakis, S., Radhakrishna, U., Kelsell, D.P., Christianson, A.L., Pitaval, A., Der K, V., Fraser, C., Blanchet-Bardon, C., Rouleau, G.A., Waksman, G. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat. Genet., 2000, 26: 142-144.
39. Richard, G., Smith, L.E., Bailey, R.A., Itin, P., Hohl, D., Epstein, E.H. Jr., DiGiovanna, JJ., Compton, J.G., Bale, S.J. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat. Genet., 1998, 20: 366-369.
40. Wenzel, K., Manthey, D., Willecke, K., Grzeschik, K.H., Traub, O. Human gap junction protein connexin31: molecular cloning and expression analysis. Biochem. Biophys. Res. Commun., 1998, 248: 910-915.
41. Richard, G., Brown, N., Smith, L.E., Terrinoni, A., Melino, G., Mackie, R.M., Bale, S.J., Uitto, J. The spectrum Of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum. Genet., 2000, 106: 321-329.
42. Liu, X.Z., Xia, X.J., Xu, L.R., Pandya, A., Liang, C.Y., Blanton, S.H., Brown, S.D., Steel, K.P., Nance, W.E. Mutations in connexin31 underlie recessive as well as dominant non- syndromic hearing loss. Hum. Mol. Genet., 2000, 9: 63-67.
43. Lopez-Bigas, N., Olive, M., Rabionet, R., Ben David, O., Martinez-Matos, J.A., Bravo, O., Banchs. I., Volpini, V., Gasparini, P., Avraham, K.B., Ferrer, I., Arbones, M.L., Estivill, X: Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment. Hum, Mol. Genet., 2001, 10: 947-952.
44. Bergoffen, J., Scherer, S.S., Wang, S., Scott, M.O., Bone, L.J., Paul, D.L., Chen, K., Lensch, M.W., Chance, P.F., Fischbeck, K.H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science, 1993, 262: 2039-2042.
45. Kumar, N.M. and Gilula, N.B. The gap junction communication channel. Cell, 1996, 84: 381-388.
46. Stojkovic, T., Latour, P., Vandenberghe, A., Hurtevent, J.F., Vermersch, P. Sensorineural deafness in X-linked Charcot-Marie-tooth disease with connexin 32 mutation (R142Q). Neurology, 1999, 52: 1010-1014.
47. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Caignec, C.L., Wegner, M., Goossens, M. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet., 2000, 9: 1907-1917.
48. Willecke, K., Jungbluth, S., Dahl, E., Hennemann, H., Heynkes, R., Grzeschik, K.H. Six genes of the human connexin gene family coding for gap junctional proteins are assigned to four different human chromosomes. Eur. J. Cell Biol., 1990, 53: 275-280.
49. Corcos, I.A., Meese, E.U., Loch-Caruso, R. Human connexin43 gene locus, GJA 1, sublocalized to band 6q21-q23.2. Cytogenet. Cell Genet., 1993, 64: 31-32.
50. Li, J.Y., Hou, X.E., Dahlstrom, A. GAP-43 and its relation to autonomic and sensory neurons in sciatic nerve and gastrocnemius muscle in the rat. J. Auton. Nerv. Syst., 1995, 50: 299-309.
51. Oviedo-Orta, E., Hoy, T., Evans, W.H. Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations. Immunology, 2000, 99: 578-590.
52. Liu, X.Z., Xia, X.J., Adams, J., Chen, Z.Y., Welch, K.O., Tekin, M., Ouyang, X.M., Kristiansen, A., Pandya, A., Balkany, T., Arnos, K.S., Nance, W.E. Mutations in GJA 1 (connexin 43) are associated with non-syndromic autosomal recessive deafness. Hum. Mol. Genet., 2001, 10: 2945-2951.
53. Liu, X.Z., Xia, X.J., Xu, L.R., Pandya, A., Liang, C.Y., Blanton, S.H., Brown, S.D., Steel, K.P., Nance, W.E. Mutations in connexin31 underlie recessive as well as dominant non- syndromic hearing loss. Hum. Mol. Genet., 2000, 9: 63-67.
54. Coucke, P.J., Van Hauwe, P., Kelley, P.M., Kunst, H., Schatteman, I., Van Velzen, D., Meyers, J., Ensink, R.J., Verstreken, M., Declau, F., Marres, H., Kastury, K., Bhasin, S., McGuirt, W.T., Smith, R.J., Cremers, C.W., Van de, H.P., Willems, P.J., Smith, S.D., Van Camp, G. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum. Mol. Genet., 1999, 8: 1321-1328
55. Kubisch, C., Schroeder, B.C., Friedrich, T., Lutjohann, B., El Amraoui, A., Marlin, S., Petit, C., Jentsch, T.J. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell, 1999, 96: 437-446.
56. Kharkovets, T., Hardelin, J.P., Safieddine, S., Schweizer, M., El Amraoui, A., Petit, C., Jentsch, T.J. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. USA, 2000, 97:4333-4338.
57. Keating, M., Dunn, C., Atkinson, D., Timothy, K., Vincent, G.M,, Leppert, M. Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am. J. Hum. Genet., 1991, 49: 1335-1339.
58. Splawski, I., Shen, J., Timothy, K.W., Vincent, G.M., Lehmann, M.H., Keating, M.T. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics, 1998, 51: 86-97.
59. Lee, M.P., Hu, R.J., Johnson, L.A., Feinberg, A.P. Human KVLQT 1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet., 1997, 15: 181-185.
60. Barhanin, J., Lesage, F., Guillemare, E., Fink, M., Lazdunski, M., Romey, G. K(V)LQT1 and 1sK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature, 1996, 384: 78-80.
61. Tinel, N., Diochot, S., Borsotto, M., Lazdunski, M., Barhanin, J. KCNE2 confers background Current characteristics to the cardiac KCNQ1 potassium channel. EMBO J., 2000, 19: 6326-6330.
62. Curran, M.E., Splawski, I, Timothy, K.W., Vincent, G.M., Green, E.D., Keating, M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell, 1995, 80: 795-803.
63. George, A.L. Jr., Varkony, T.A., Drabkin, H.A., Han, J., Knops, J.F., Finley, W.H., Brown, G.B., Ward, D.C., Haas, M. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p2l. Cytogenet. Cell Genet., 1995, 68: 67-70.
64. Wang, Q., Li, Z., Shen, J., Keating, M.T. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics, 1996, 34: 9-16.
65. Chevillard, C., Attali, B., Lesage, F., Fontes, M., Barhanin, J., Lazdunski, M., Mattei, M.G. Localization of a potassium channel gene (KCNE1) to 21q22.1-q22.2 by in situ hybridization and somatic cell hybridization. Genomics, 1993, 15: 243-245.
66. Abbott, G.W., Sesti, F., Splawski, I., Buck, M.E., Lehmann, M.H., Timothy, K.W., Keating, M.T., Goldstein, S.A. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell, 1999, 97: 175-187.
67. Sesti, F., Abbott, G.W., Wei, J., Murray, K.T., Saksena, S., Schwartz, P.J., Priori, S.G., Roden, D.M., George, A.L. Jr., Goldstein, S.A. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc. Natl. Acad. Sci. USA, 2000, 97: 10613-10618.
68. Everett, L.A., Glaser, B., Beck, J.C., Idol, J.R., Buchs, A., Heyman, M., Adawi, F., Hazani, E., Nassir, E., Baxevanis, A.D., Sheffield, V.C., Green, E.D. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet., 1997, 17: 411-422.
69. Scott, D.A., Wang, R., Kreman, T.M., Sheffield, V.C., Karniski, L.P. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat. Genet., 1999, 21: 440-443.
70. Bidart, J.M., Mian, C., Lazar, V., Russo, D., Filetti, S., Caillou, B., Schlumberger, M. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J. Clin. Endocrinol. Metab., 2000, 85: 2028-2033.
71. Scott, D.A., Wang, R., Kreman, T.M., Andrews, M., McDonald, J.M., Bishop, J.R., Smith, R.J., Karniski, L.P., Sheffield, V.C. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non- syndromic hearing loss (DFNB4). Hum. Mol. Genet., 2000, 9: 1709-1715.
72. Mustapha, M., Salem, N., Weil, D., El Zir, E., Loiselet, J., Petit ,C. Identification of a locus on chromosome 7q31, DFNB14, responsible for prelingual sensorineural nonsyndromic deatness. Eur.J. Hum. Genet., 1998, 6: 548-551.
73. Greinwald, J.H. Jr., Wayne, S., Chen, A.H., Scott, D.A., Zbar, R.I., Kraft, M.L., Prasad, S., Ramesh, A., Coucke, P., Srisailapathy, C.R., Lovett, M., Van Camp, G., Smith, R.J. Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31. Am.J. Med. Genet., 1998, 78: 107-113.
74. Karet, F.E., Finberg, K.E., Nelson, R.D., Nayir, A., Mocan, H., Sanjad, S.A., Rodriguez-Soriano, J., Santos, F., Cremers, C.W., Di Pietro, A., Hoffbrand, B.I., Winiarski, J., Bakkaloglu, A., Ozen, S., Dusunsel, R., Goodyer, P., Hulton, S.A., Wu, D.K., Skvorak, A.B., Morton, C.C., Cunningham, M.J., Jha, V., Lifton, R.P. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness [see comments]. Nat. Genet., 1999, 21: 84-90.
75. Hattori, M., Fujiyama, A., Taylor, T.D., Watanabe, H., Yada, T., Park, H.S., Toyoda, A., Ishii, K., Totoki, Y., Choi, D.K., Soeda, E., Ohki, M., Takagi, T., Sakaki, Y., Taudien, S., Blechschmidt, K., Polley, A., Menzel, U., Delabar, J., Kumpf, K., Lehmann, R., Patterson, D., Reichwald, K., Rump, A., Schillhabel, M., Schudy, A., Zimmermann, W., Rosenthal, A., Kudoh, J., Schibuya, K., Kawasaki, K., Asakawa, S., Shintani, A., Sasaki, T., Nagamine, K., Mitsuyama, S., Antonarakis, S.E., Minoshima, S., Shimizu, N., Nordsiek, G., Hornischer, K., Brant, P., Scharfe, M., Schon, O., Desario, A., Reichelt, J., Kauer, G., Blocker, H., Ramser, J., Beck, A., Klages, S., Hennig, S., Riesselmann, L., Dagand, E., Haaf, T., Wehrmeyer, S., Borzym, K., Gardiner, K., Nizetic, D., Francis, F., Lehrach, H., Reinhardt, R., Yaspo, M.L. The DNA sequence of human chromosome 21. Nature, 2000, 405: 311-319.
76. Wilcox, E.R., Burton, Q.L., Naz, S., Riazuddin, S., Smith, T.N., Ploplis, B., Belyantseva, I., Ben Yosef, T., Liburd, N.A., Morell, R.J., Kachar, B., Wu, D.K., Griffith,-A.J., Riazuddin, S., Friedman, T.B. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell, 2001, 104: 165-172.
77. Legan, P.K., Rau, A., Keen, J.N., Richardson, G.P. The mouse tectorins. Modular matrix proteins of the inner ear homologous to components of the sperm-egg adhesion system. J. Biol. Chem., 1997, 272: 8791-8801.
78. Mustapha, M., Weil, D., Chardenoux, S., Elias, S., El Zir, E., Beckmann, J.S., Loiselet, J., Petit, C. An alpha-tectorin gene defect causes a newly identified autosomal recessive form of sensorineural pre-lingual non-syndromic deafness, DFNB21. Hum. Mol. Genet., 1999, 8: 409-412.
79. Verhoeven, K., Van Laer, L., Kirschhofer, K., Legan, P.K., Hughes, D.C., Schatteman, I., Verstreken, M., Van Hauwe, P., Coucke, P., Chen, A., Smith, R.J., Somers, T., Offeciers, F.E., Van de, H.P., Richardson, G.P., Wachtler, F., Kimberling, W.J., Willems, P.J., Govaerts, P.J., Van Camp, G. Mutations in the human alpha-tectorin gene cause autosomal dominant non- syndromic hearing impairment. Nat. Genet., 1998, 19: 60-62.
80. Verhoeven, K., Van Laer, L., Kirschhofer, K., Legan, P.K., Hughes, D.C., Schatteman, I., Verstreken, M., Van Hauwe, P., Coucke, P., Chen, A., Smith, R.J., Somers, T., Offeciers, F.E., Van de, H.P., Richardson, G.P., Wachtler, F., Kimberling, W.J., Wiliems, P.J., Govaerts, P.J., Van Camp, G. Mutations in the human alpha-tectorin gene cause autosomal dominant non- syndromic hearing impairment. Nat. Genet., 1998, 19: 60-62.
81. Balciuniene, J., Dahl, N., Jalonen, P., Verhoeven, K., Van Camp, G., Borg, E., Pettersson, U., Jazin, E.E. Alphatectorin involvement in hearing disabilities: one gene--two phenotypes. Hum. Genet., 1999, 105: 211-216.
82. Legan, P.K., Lukashkina, V.A., Goodyear, R.J., Kossi, M., Russell, I.J., Richardson, G.P. A targeted deletion in alphatectorin reveals that the tectorial membrane is required for the gain and timing of cochlear feedback. Neuron., 2000. 28: 273-285.
83. Manolis, E.N., Yandavi, N., Nadol, J.B. Jr., Eavey, R.D., McKenna, M., Rosenbaum, S., Khetarpal, U., Halpin, C., Merchant, S. N., Duyk, G.M., MacRae, C., Seidman, C.E., Seidman, J.G. A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12-13. Hum. Mol. Genet., 1996, 5: 1047-1050.
84. Khetarpal, U., Schuknecht, H.F., Gacek, R.R., Holmes, L.B. Autosomal dominant sensorineural hearing loss. Pedigrees, audiologic findings, and temporal bone findings in two kindreds. Arch. Otolaryngol. Head Neck Surg., 1991, 117: 1032-1042.
85. Khetarpal, U. Autosomal dominant sensorineural hearing loss. Further temporal bone findings. Arch. Otolaryngol. Head Neck Surg., 1993, 119: 106-108.
86. de Kok, Y.J., Bom, S.J., Brunt, T.M., Kemperman, M.H., van Beusekom, E., van der Velde-Visser, S.D., Robertson, N.G., Morton, C.C., Huygen, P.L., Verhagen, W.I., Brunner, H.G., Cremers, C.W., Cremers, F.P. A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum. Mol. Genet., 1999, 8: 361-366.
87. Robertson, N.G., Skvorak, A.B., Yin, Y., Weremowicz, S., Johnson, K.R., Kovatch, K.A., Battey, J.F., Bieber, F.R., Morton, C.C. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics, 1997, 46: 345-354.
88. Robertson, N.G., Lu, L., Heller, S., Merchant, S.N., Eavey, R.D., McKenna M, Nadol, J.B. Jr., Miyamoto, R.T., Linthicum, F.H. Jr., Lubianca, Neto, J.F., Hudspeth, A.J., Seidman, C.E., Morton, C.C., Seidman, J.G. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat. Genet., 1998, 20: 299-303.
89. Fransen, E. and Van Camp, G. The COCH gene: a frequent cause of hearing impairment and vestibular dysfunction? Br. J. Audiol., 1999, 33: 297-302.
90. Richards, A.J., Yates, J.R., Williams, R., Payne, S.J., Pope, F.M., Scott, J.D., Snead, M.P. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum. Mol. Genet., 1996, 5: 1339-1343.
91. Zhidkova, N.I., Justice, S.K., Mayne, R. Alternative mRNA processing occurs in the variable region of the pro- alpha 1(XI) and pro-alpha 2(XI) collagen chains. J. Biol. Chem., 1995, 270: 9486-9493.
92. Annunen, S., Korkko, J., Czarny, M., Warman, M.L., Brunner, H.G., Kaariainen, H., Mulliken, J.B., Tranebjaerg, L., Brooks, D.G., Cox, G.F., Cruysberg, J.R., Curtis, M.A., Davenport, S.L., Friedrich, C.A., Kaitila, I., Krawczynski, M.R., Latos-Bielenska, A., Mukai, S., Olsen, B.R., Shinno, N., Somer, M., Vikkula, M., Zlotogora, J., Prockop, D.J., Ala-Kokko, L. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations Cause overlapping Marshall/Stickler phenotypes. Am. J. Hum. Genet., 1999, 65: 974-983.
93. Martin, S., Richards, A.J., Yates, J.R., Scott, J.D., Pope, M., Snead, M.P. Stickler syndrome: further mutations in COL11A1 and evidence for additional locus heterogeneity. Eur. J. Hum. Genet., 1999, 7:807-814.
94. Vuristo, M.M., Pihlajamaa, T., Vandenberg, P., Prockop, D.J., Ala-Kokko, L. The human COL11A2 gene structure indicates that the gene has not evolved with the genes for the major fibrillar collagens. J. Biol. Chem., 1995, 270: 22873-22881.
95. Pihlajamaa, T., Prockop, D.J., Faber, J., Winterpacht, A., Zabel, B., Giedion, A., Wiesbauer, .P, Spranger, J., AlaKokko, L. Heterozygous glycine Substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymuller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome). Am. J. Med. Genet., 1998, 80: 115-120.
96. Francomano, C.A., Liberfarb, R.M., Hirose, T., Maumenee, I.H., Streeten, E.A., Meyers, D.A., Pyeritz, R.E. The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics, 1987, 1: 293-296.
97. Knowlton, R.G., Weaver, E.J., Struyk, A.F., Knobloch, W.H., King, R.A., Norris, K., Shamban, A., Uitto, J., Jimenez, S.A., Prockop, D.J. Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am. J. Hum. Genet., 1989, 45: 681-688.
98. Spranger, J., Menger, H., Mundlos, S., Winterpacht, A., Zabel, B. Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal-dysplasia. Pediatr. Radiol., 1994, 24: 431-435.
99. Vikkula, M., Metsaranta, M., Ala-Kokko, L. Type II collagen mutations in rare and common cartilage diseases. Ann. Med., 1994, 26: 107-114.
100. Kuivaniemi, H., Tromp, G., Prockop, D.J. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum. Mutat., 1997, 9: 300-315.
101. Yoo, T.J., Tomoda, K., Stuart, J.M., Cremer, M.A., Townes, A.S., Kang, A.H. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann. Otol. Rhinol. Laryngol., 1983, 92: 267-271.
102. Helfgott, S.M., Mosciscki, R.A., San Martin, J., Lorenzo, C., Kieval, R., McKenna, M., Nadol, J., Trentham, D.E. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet, 1991, 337: 387-389.
103. So, C.L., Kaluarachchi, K., Tam, P.P., Cheah, K.S. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis. Cartilage., 2001, 9 Suppl A: S160-S173.
104. Sahlman, J., Inkinen, R., Hirvonen, T., Lammi, M.J., Lammi, P.E., Nieminen, J., Lapvetelainen, T., Prockop, D.J., Arita, M., Li, S.W., Hyttinen, M.M., Helminen, H.J., Puustjarvi, K. Premature vertebral endplate ossification and mild disc degeneration in mice after inactivation of one allele belonging to the Col2a1 gene for Type II collagen. Spine, 2001, 26: 2558-2565.
105. Butkowski, R.J., Langeveld, J.P., Wieslander, J, Hamilton, J., Hudson, B.G. Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J. Biol. Chem., 1987, 262: 7874-7877.
106. Saus, J., Wieslander, J., Langeveld, J.P., Quinones, S., Hudson, B.G. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J. Biol. Chem., 1988, 263: 13374-13380.
107. Hudson, B.G., Kalluri, R., Gunwar, S., Weber, M., Ballester, F., Hudson, J.K., Noelken, M.E., Sarras, M., Richardson, W.R., Saus, J. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int., 1992, 42: 179-187.
108. Jefferson, J.A., Lemmink, H.H., Hughes, A.E., Hill, C.M., Smeets, H.J., Doherty, C.C., Maxwell, A.P. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol. Dial. Transplant., 1997, 12: 1595-1599.
109. Leinonen, A., Mariyama, M., Mochizuki, T., Tryggvason, K., Reeders, S.T. Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains. J. Biol. Chem., 1994, 269: 26172-26177.
110. Boye, E., Mollet, G., Forestier, L., Cohen-Solal, L., Heidet, L., Cochat, P., Grunfeld, J.P., Palcoux, J.B., Gubler, M.C., Antignac, C. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am. J. Hum. Genet., 1998, 63: 1329-1340.
111. Lemmink, H.H., Schroder, C.H., Monnens, L.A., Smeets, H.J. The clinical spectrum of type IV collagen mutations. Hum. Mutat., 1997, 9: 477-499.
112. Zhou, J., Mochizuki, T., Smeets, H., Antignac, C., Laurila, P., de Paepe, A., Tryggvason, K., Reeders, S.T. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science, 1993, 261: 1167-1169.
113. Antignac, C., Knebelmann, B., Drouot, L., Gros, F., Deschenes, G., Hors-Cayla, M.C., Zhou, J., Tryggvason, K., Grunfeld, J.P., Broyer, M. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. J. Clin. Invest., 1994, 93: 1195-1207.
114. Harvey, S.J., Mount, R., Sado, Y., Naito, I., Ninomiya, Y., Harrison, R., Jefferson, B., Jacobs, R., Thorner, P.S. The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am. J. Pathol., 2001, 159: 1097-1104.
115. Berger, W., Meindl, A., van de Pol, T.J., Cremers, F.P., Ropers, H.H., Doerner, C., Monaco, A., Bergen, A.A., Lebo, R., Warburg, M. Isolation of a candidate gene for Norrie disease by positional cloning. Nat. Genet., 1992, 1: 199-203.
116. Chen, Z.Y., Sims, K.B., Coleman, M., Donnai, D., Monaco, A., Breakefield, X.O., Davies, K.E., Craig, I.W. Characterization of a YAC containing part or all of the Norrie disease locus. Hum. Mol. Genet., 1992, 1: 161-164.
117. Chen, Z.Y., Battinelli, E.M., Hendriks, R.W., Powell, J.F., Middleton-Price, H., Sims, K.B., Breakefield, X.O., Craig, I.W. Norrie disease gene: characterization of deletions and possible function. Genomics, 1993, 16: 533-535
118. Weston, M.D., Eudy, J.D., Fujita, S., Yao, S., Usami, S., Cremers, C., Greenberg, J., Ramesar, R., Martini, A., Moller, C., Smith, R.J., Sumegi, J., Kimberling, W.J., Greenburg, J. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am. J. Hum. Genet., 2000, 66: 1199-1210.
119. Cohen-Salmon, M., Mattei. M.G., Petit, C. Mapping of the otogelin gene (OTGN) to mouse chromosome 7 and human chromosome 11p14.3: a candidate for human autosomal recessive nonsyndromic deafness DFNB18. Mamm. Genome., 1999, 10: 520-522.
120. Simmler, M.C., Zwaenepoel I. I., Verpy, E., Guillaud, L., Elbaz, C., Petit, C., Panthier, J.J. Twister mutant mice are defective for otogelin, a component specific to inner ear acellular membranes. Mamm. Genome., 2000, 11: 961-966.
121. Zwaenepoel, I., Mustapha, M., Leibovici, M., Verpy, E., Goodyear, R., Liu, X.Z., Nouaille, S., Nance, W.E., Kanaan, M., Avraham, K.B., Tekaia, F., Loiselet, J., Lathrop, M., Richardson, G., Petit, C. Otoancorin, an inner ear protein restricted to the interface between the apical surface of sensory epithelia and their overlying acellular gels, is defective in autosomal recessive deafness DFNB22. Proc. Natl. Acad. Sci. USA, 2002, 99: 6240-6245.
122. MacDougall, M., Simmons, D., Luan, X., Gu, T.T., DuPont, B.R. Assignment of dentin sialophosphoprotein (DSPP) to the critical DGI2 locus on human chromosome 4 band q21.3 by in situ hybridization. Cytogenet. Cell Genet., 1997, 79: 121-122.
123. Takagi, Y. and Sasaki, S. A probable common disturbance in the early stage of odontoblast differentiation in Dentinogenesis imperfecta type I and type II. J. Oral Pathol., 1988, 17: 208-212.
124. Crosby AH, Scherpbier-Heddema T, Wijmenga C, Altherr MR, Murray JC, Buetow KH, Dixon MJ: Genetic mapping of the dentinogenesis imperfecta type II locus. Am. J. Hum. Genet., 1995, 57: 832-839.
125. Zhang, X., Zhao, J., Li, C., Gao, S., Qiu, C., Liu, P., WU, G., Qiang, B., Lo, W.H., Shen, Y. DSPP mutation in dentinogenesis imperfecta Shields type II. Nat. Genet., 2001, 27: 151-152.
126. Xiao, S., Yu, C., Chou, X., Yuan, W., Wang, Y., Bu L., Fu, G., Qian, M., Yang, J., Shi, Y., Hu, L., Han, B., Wang, Z., Huang, W., Liu, J., Chen, Z., Zhao, G., Kong, X. Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat. Genet., 2001, 27: 201-204.
127. Begue-Kirn, C., Krebsbach, P.H., Bartlett, J.D., Butler, W.T. Dentin sialoprotein, dentin phosphoprotein, enamelysin and ameloblastin: tooth-specific molecules that are distinctively expressed during murine dental differentiation. Eur. J. Oral Sci., 1998, 106: 963-970.
128. Verpy, E., Leibovici, M., Zwaenepoel, I., Liu, X.Z., Gal, A., Salem, N., Mansour, A., Blanchard, S., Kobayashi, I., Keats, B.J., Slim, R., Petit, C. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat. Genet., 2000, 26: 51-55.
129. Bitner-Glindzicz, M., Lindley, K.J., Rutland, P., Blaydon, D., Smith, V.V., Milla, P.J., Hussain, K., Furth-Lavi, J., Cosgrove, K.E., Shepherd, R.M., Barnes, P.D., O'Brien, R.E., Farndon, P.A. Sowden, J., Liu, X.Z., Scanlan, M.J., Malcolm, S., Dunne, M.J., Aynsley-Green, A., Glaser, B. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat. Genet., 2000, 26: 56-60.
130. Montell, C. A PDZ protein ushers in new links. Nat. Genet., 2000, 26: 6-7.
131. Ahmed, Z., Smith, T., Riazuddin, S., Makishima; T., Gosh, M., Bokhari, S., Menon, P.S., Deshmukh, D., Griffith, A.J., Riazuddin, S., Friedman, T.B., Wilcox, E.R. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum. Genet., 2002, 110: 527-531.
132. Leon, P.E., Bonilla, J.A., Sanchez, J.R., Vanegas, R., Villalobos, M., Torres, L., Leon, F., Howell, A.L., Rodriguez, J.A. Low frequency hereditary deafness in man with childhood onset. Am. J. Hum. Genet., 1981, 33: 209-214.
133. Leon, P.E., Raventos, H., Lynch, E., Morrow, J., King, M.C. The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl. Acad. Sci. USA, 1992, 89: 5181-5184.
134. Lynch, E.D., Lee, M.K., Morrow, J.E., Welcsh, P.L., Leon, P.E., King, M.C. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science, 1997, 278: 1315-1318.
135. Tyson, J., Bellman, S., Newton, V., Simpson, P., Malcolm, S., Pembrey, M.E., Bitner-Glindzicz, M. Mapping of DFN2 to Xq22. Hum. Mol. Genet., 1996, 5: 2055-2060.
136. de Kok, Y.J., van der Maarel, S.M., Bitner-Glindzicz, M., Huber, I., Monaco, A.P., Malcolm, S., Pembrey, M.E., Ropers HH, Cremers FP: Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science. 1995, 267: 685-688.
137. Bitner-Glindzicz, M., Turnpenny, P., Hoglund, P., Kaariainen, H., Sankila, E.M., van der Maarel, S.M., de Kok, Y.J., Ropers, H.H., Cremers, F.P., Pembrey, M. Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X- linked deafness, DFN-33. Hum. Mol. Genet., 1995, 4: 1467-1469.
138. Minowa, O., Ikeda, K., Sugitani, Y., Oshima, T., Nakai, S., Katori, Y., Suzuki, M., Furukawa, M., Kawase, T., Zheng, Y., Ogura, M., Asada, Y., Watanabe, K., Yamanaka, H., Gotoh, S., Nishi-Takeshima, M., Sugimoto, T., Kikuchi, T., Takasaka, T., Noda, T. Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science, 1999, 285: 1408-1411.
139. Phippard, D., Boyd, Y., Reed, V., Fisher, G., Masson, W.K., Evans, E.P., Saunders, J.C., Crenshaw, E.B., III. The sex-linked fidget mutation abolishes Brn4/Pou3f4 gene expression in the embryonic inner ear. Hum. Mol. Genet., 2000, 9: 79-85.
140. Xiang, M., Zhou, L., Macke, J.P., Yoshioka, T., Hendry, S.H., Eddy, R.L., Shows, T.B., Nathans, J. The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J. Neurosci., 1995, 15: 4762-4785.
141. Vahava, O., Morell, R., Lynch, E.D., Weiss, S., Kagan, M.E., Ahituv, N., Morrow, J.E., Lee, M.K., Skvorak, A.B., Morton, C.C., Blumenfeld, A., Frydman, M., Friedman, T.B., King, M.C., Avraham, K.B. Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science, 1998, 279: 1950-1954.
142. Xiang, M., Gan, L., Li, D., Chen, Z.Y., Zhou, L., O'Malley, B.W. Jr., Klein, W., Nathans, J. Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc. Natl. Acad. Sci. USA, 1997, 94: 9445-9450.
143. Erkman, L., McEvilly, R.J., Luo, L., Ryan, A.K., Hooshmand, F., O'Connell, S.M., Keithley, E.M., Rapaport, D.H., Ryan, A.F., Rosenfeld, M.G. Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature, 1996, 381: 603-606.
144. Frydman, M., Vreugde, S., Nageris, B.I., Weiss, S., Vahava, O., Avraham, K.B. Clinical characterization of genetic hearing loss caused by a mutation in the POU4F3 transcription factor. Arch. Otolaryngol. Head Neck Surg., 2000, 126: 633-637.
145. Azuma, N., Hirakiyama, A., Inoue, T., Asaka, A., Yamada, M. Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies. Hum. Mol. Genet., 2000, 9: 363-366.
146. Abdelhak, S., Kalatzis, V., Heilig, R., Compain. S., Samson, D., Vincent, C., Levi-Acobas, F., Cruaud, C., Le Merrer, M., Mathieu, M., Konig, R., Vigneron, J., Weissenbach, J., Petit, C., Weil, D. Clustering, of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum. Mol. Genet., 1997, 6: 2247-2255.
147. Melnick, M., Bixler, D., Silk, K., Yune, H., Nance, W.E. Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig. Artic. Ser., 1975, 11: 121-128.
148. Fraser, F.C., Ling, D., Clogg, D., Nogrady, B. Genetic aspects of the BOR syndrome--branchial fistulas, ear pits, hearing loss, and renal anomalies. Am. J. Med. Genet., 1978, 2: 241-252.
149. Abdelhak, S., Kalatzis, V., Heilig, R., Compain, S., Samson, D., Vincent, C., Weil, D., Cruaud, C., Sahly, I., Leibovici, M., Bitner-Glindzicz, M., Francis, M., Lacombe, D., Vigneron, J., Charachon, R., Boven, K., Bedbeder, P., Van Regemorter, N., Weissenbach, J., Petit, C. A human homologue of the Drosophila eyes absent gene underlies branchio- oto-renal (BOR) syndrome and identifies a novel gene family. Nat. Genet., 1997, 15: 157-164.
150. Vincent, C., Kalatzis, V., Abdelhak, S., Chaib, H., Compain, S., Helias, J., Vaneecloo, F.M., Petit, C. BOR and BO syndromes are allelic defects of EYA1. Eur. J. Hum. Genet. 1997, 5: 242-246.
151. Stratakis, C.A., Lin, J.P., Rennert,, O.M. Description of a large kindred with autosomal dominant inheritance of branchial arch anomalies, hearing loss, and ear pits, and exclusion of the branchio-oto-renal (BOR) syndrome gene locus (chromosome 8q13.3). Am. J. Med. Genet., 1998, 79: 209-214.
152. Rickard, S., Boxer, M., Trompeter, R., Bitner-Glindzicz, M. Importance of clinical evaluation and molecular testing in the branchio- oto-renal (BOR) syndrome and overlapping phenotypes. J. Med. Genet., 2000, 37: 623-627.
153. Xu, P.X., Adams, J., Peters, H., Brown, M.C., Heaney, S., Maas, R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat.Genet. 1999, 23: 113-117.
154. Borsani, G., DeGrandi, A., Ballabio, A., Bulfone, A., Bernard, L., Banfi, S., Gattuso, C., Mariani, M., Dixon, M., Donnai, D., Metcalfe, K., Winter, R., Robertson, M., Axton, R., Brown, A., van H, V., Hanson, I. EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum. Mol. Genet., 1999, 8: 11-23.
155. Wayne, S., Robertson, N.G., Declau, F., Chen, N., Verhoeven, K., Prasad, S., Tranebjarg, L., Morton, C.C., Ryan, A.F., Van Camp, G., Smith, R.J. Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum. Mol. Genet., 2001, 10: 195-200.
156. Tachibana, M., Perez-Jurado, L.A., Nakayama, A., Hodgkinson, C.A., Li, X., Schneider, M., Miki, T., Fex, J., Francke, U., Arnheiter, H. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum. Mol. Genet., 1994, 3: 553-557.
157. Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J.E., Meyers, K.A., Aaronson, S.A., Miki, T. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat. Genet., 1996, 14: 50-54.
158. Watanabe, A., Takeda, K., Ploplis, B., Tachibana, M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet., 1998, 18: 283-286.
159. Hoth, C.F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S.K., Baldwin, C.T. Mutations in the paired domain of the human PAX3 gene cause Klein- Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet., 1993, 52: 455-462.
160. Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P., Strachan, T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature, 1992, 355: 635-636,
161. Tassabehji, M., Newton, V.E., Leverton, K., Turnbull, K., Seemanova, E., Kunze, J., Sperling, K., Strachan, T., Read, A.P. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum. Mol. Genet., 1994, 3: 1069-1074.
162. Goulding, M.D., Chalepakis, G., Deutsch, U., Erselius, J.R., Gruss, P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J., 1991, 10: 1135-1147.
163. Burri, M., Tromvoukis, Y., Bopp, D., Frigerio, G., Noll, M. Conservation of the paired domain in metazoans and its structure in three isolated human genes. EMBO J., 1989, 8: 1183-1190.
164. Tsukamoto, K., Nakamura, Y., Niikawa, N. Isolation of two isoforms of the PAX3 gene transcripts and their tissue-specific alternative expression in human adult tissues. Hum. Genet., 1994, 93: 270-274.
165. Epstein, D.J., Vekemans, M., Gros, P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell, 1991, 67: 767-774.
166. Steel, K.P. and Smith, R.J. Normal hearing in Splotch (Sp/+), the mouse homologue of Waardenburg syndrome type 1. Nat. Genet., 1992, 2: 75-79.
167. Pusch, C., Hustert, E., Pfeifer, D., Sudbeck, P., Kist, R., Roe, B., Wang, Z., Balling, R., Blin, N., Scherer, G. The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum. Genet., 1998, 103: 115-123.
168. Southard-Smith, E.M., Kos, L., Pavan, W.J. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet., 1998, 18: 60-64.
169. Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M, Wegner, M. Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc. Natl. Acad. Sci. USA, 1998, 95: 5161-5165.
170. Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D.E., Prehu, M.O., Puliti, A., Herbarth, B, Hermans-Borgmeyer, I., Legius, E., Matthijs, G., Amiel, J., Lyonnet, S., Ceccherini, I., Romeo, G., Smith, J.C., Read, A.P., Wegner, M., Goossens. M. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet., 1998, 18: 171-173
171. Lee, M., Goodall, J., Verastegui, C., Ballotti, R., Goding, C.R. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem., 2000, 275: 37978-37983.
172. Bondurand, N., Kuhlbrodt, K., Pingault, V., Enderich, J., Sajus, M., Tommerup, N., Warburg, M., Hennekam, R.C., Read, A.P., Wegner, M., Goossens, M. A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum. Mol. genet., 1999, 8: 1785-1789.
173. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988, 332: 411-415.
174. Komuro, I., Kurihara, H., Sugiyama, T., Yoshizumi, M., Takaku, F., Yazaki, Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett., 1988, 238: 249-252.
175. Takuwa, N., Takuwa, Y., Yanagisawa, M., Yamashita, K., Masaki, T. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem., 1989, 264: 7856-7861.
176. Shichiri, M., Hirata, Y., Kanno, K., Ohta, K., Emori, T., Marumo, F. Effect of endothelin-1 on release of arginine-vasopressin from perifused rat hypothalamus. Biochem. Biophys. Res. Commun., 1989, 163: 1332-1337.
177. Takayanagi, R., Ohnaka, K., Takasaki, C., Ohashi, M., Nawata, H. Multiple subtypes of endothelin receptors in human and porcine tissues: characterization by ligand binding, affinity labeling, and regional distribution. J. Cardiovasc. Pharmacol 1991, 17 Suppl 7: S127-S130.
178. Williams, D.L. Jr., Jones, K.L., Colton, C.D., Nutt, R.F. Identification of high affinity endothelin-1 receptor subtypes in human tissues. Biochem. Biophys. Res. Commun., 1991, 180: 475-480.
179. Arai, H., Nakao, K., Takaya, K., Hosoda, K., Ogawa, Y., Nakanishi, S., Imura, H. The human endothelin-B receptor gene. Structural organization and chromosomal assignment. J. Biol. Chem., 1993, 268: 3463-3470.
180. Puffenberger, E.G., Hosoda, K., Washington, S.S., Nakao, K., deWit, D., Yanagisawa, M., Chakravart, A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell, 1994, 79: 1257-1266.
181. Kusafuka, T., Wang, Y., Puri, P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum. Mol. Genet., 1996, 5: 347-349.
182. Syrris, P., Carter, N.D., Patton, M.A. Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease. Am. J. Med. Genet., 1999, 87: 69-71.
183. Attie, T., Till, M., Pelet, A., Amiel, J., Edery, P., Boutrand, L., Munnich, A., Lyonnet, S. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum. Mol. Genet., 1995, 4: 2407-2409.
184. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., Masaki, T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA, 1989, 86: 2863-2867.
185. Dupin, E., Glavieux, C., Vaigot, P., Le Douarin. N.M. Endothelin 3 induces the reversion of melanocytes to glia through a neural crest-derived glial-melanocytic progenitor. Proc. Natl. Acad. Sci. USA, 2000, 97: 7882-7887.
186. Rao, V.V., Loffler, C., Hansmann. I. The gene for the novel vasoactive peptide endothelin 3 (EDN3) is localized to human chromosome 20q13.2-qter. Genomics, 1991, 10: 840-841.
187. Arinami, T., Ishikawa, M., Inoue, A., Yanagisawa, M., Masaki, T., Yoshida, M.C., Hamaguchi, H. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. Am. J. Hum. Genet., 1991, 48: 990-996.
188. Bloch, K.D., Eddy, R.L., Shows, T.B., Quertermous, T. cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J. Biol. Chem., 1989, 264: 18156-18161.
189. Baynash, A.G., Hosoda, K., Giaid, A., Richardson, J.A., Emoto, N., Hammer, R.E., Yanagisawa, M. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell, 1994, 79: 1277-1285.
190. Edery, P., Attie, T., Amiel, J., Pelet, A., Eng, C., Hofstra, R.M., Martelli, H., Bidaud, C., Munnich, A., Lyonnet, S. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat. Genet., 1996, 12: 442-444.
191. Keegan, K., Johnson, D.E., Williams, L.T., Hayman, M.J. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA, 1991, 88: 1095-1099.
192. Thompson, L.M., Plummer, S., Schalling, M., Altherr, M.R., Gusella, J.F., Housman, D.E., Wasmuth, J.J. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics, 1991, 11: 1133-1142.
193. Perez-Castro, A.V., Wilson, J., Altherr, M.R. Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene. Genomics, 1997, 41: 10-16.
194. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T., Wasmuth, J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 1994, 78: 335-342.
195. Hunter, A.G., Bankier, A., Rogers, J.G., Sillence, D., Scott, C.I. Jr. Medical complications of achondroplasia: a multicentre patient review. J. Med. Genet., 1998, 35: 705-712.
196. Naski, M.C., Wang, Q., Xu, J., Ornitz, D.M. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet., 1996, 13: 233-237.
197. Henderson, J.E., Naski, M.C., Aarts, M.M., Wane, D., Cheng, L., Goltzman, D., Ornitz, D.M. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J. Bone Miner. Res., 2000, 15: 155-165.
198. Walsh, T., Walsh, V., Vreugde. S., Hertzano, R., Shahin, H., Haika, S., Lee, M.K., Kanaan, M., Kine. M.C., Avraham KB: From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc. Natl. Acad. Sci. USA. 2002. 99: 7518-7523
199. Weil, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levilliers, J., Weston, M.D. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature, 1995, 374: 60-61.
200. Wagenaar, M., ter Rahe, B., Van Aarem, A., Huygen, P., Admiraal, R., Bleeker-Wagemakers, E., Pinckers, A., Kimberling, W., Cremers, C. Clinical findings in obligate carriers of type I Usher syndrome. Am. J. Med. Genet., 1995, 59: 375-379.
201. Guilford, P., Ayadi, H., Blanchard, S., Chaib, H., Le Paslier, D., Weissenbach, J., Drira, M., Petit, C. A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum. Mol. Genet., 1994, 3: 989-993.
202. Tamagawa, Y., Kitamura, K., Ishida, T., Ishikawa, K., Tanaka, H., Tsuji, S., Nishizawa, M. A gene for a dominant form of non-syndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum. Mol. Genet., 1996, 5: 849-852.
203. Liu, X.Z., Walsh, J., Tamagawa, Y., Kitamura, K., Nishizawa, M., Steel, K.P., Brown, S.D. Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat. Genet., 1997, 17: 268-269.
204. Weil, D., Kussel, P., Blanchard, S., Levy, G., Levi-Acobas, F., Drira, M., Ayadi, H., Petit, C. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat. Genet., 1997, 16: 191-193.
205. Tamagawa, Y., Kitamura, K., Ishida, T., Ishikawa, K., Tanaka, H., Tsuji, S., Nishizawa, M. A gene for a dominant form of non-syndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum. Mol. Genet., 1996, 5: 849-852.
206. Liu, X.Z., Walsh, J., Tamagawa, Y., Kitamura, K., Nishizawa, M., Steel, K.P., Brown, S.D. Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat. Genet., 1997, 17: 268-269.
207. Weil, D., Kussel, P., Blanchard, S., Levy, G., Levi-Acobas, F., Drira, M., Ayadi, H, Petit, C. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat. Genet., 1997, 16: 191-193.
208. Kelley, P.M., Weston, M.D., Chen, Z.Y., Orten, D.J., Hasson, T., Overbeck, L.D., Pinnt, J., Talmadge, C.B., Ing, P., Mooseker, M.S., Corey, D., Sumegi, J., Kimberling, W.J. The genomic structure of the gene defective in Usher syndrome type Ib (MYO7A). Genomics, 1997, 40: 73-79.
209. Friedman, T.B., Liang, Y., Weber, J.L., Hinnant, J.T., Barber, T. D., Winata, S., Arhya, I.N., Asher, J.H. Jr. A gene for congenital, recessive deafness DFNB3 maps to the pericentromeric region of chromosome 17. Nat. Genet., 1995, 9: 86-91
210. Wang, A., Liang, Y., Fridell, R.A., Probst, F.J., Wilcox, E.R., Touchman JW, Morton CC, Morell RJ, Noben-Trauth, K., Camper, S.A., Friedman, T.B. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science, 1998, 280: 1447-1451.
211. Anderson, D.W., Probst, F.J., Belyantseva, I.A., Fridell, R.A., Beyer, L., Martin, D.M., Wu, D., Kachar, B., Friedman, T.B., Raphael, Y., Camper, S.A. The motor and tail regions of myosin XV are critical for normal structure and function of auditory and vestibular hair cells. Hum. Mol. Genet., 2000, 9: 1729-1738.
212. Lalwani, A.K., Goldstein, J.A., Kelley, M.J., Luxford, W., Castelein, C.M., Mhatre, A.N. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am. Hum. Genet., 2000, 67: 1121-1128.
213. Melchionda, S., Ahituv, N., Bisceglia, L., Sobe, T., Glaser, F., Rabionet, R., Arbones, M.L., Notarangelo, A., Di Iorio, E., Carella, M., Zelante, L., Estivill, X., Avraham, K.B., Gasparini, P. MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am. J. Hum. Genet., 2001, 69: 635-640.
214. Di Palma, F., Pellegrino, R., Noben-Trauth, K. Genomic structure, alternative splice forms and normal and mutant alleles of cadherin 23 (Cdh23). Gene, 2001, 281: 31-41.
215. Chaib, H., Place, C., Salem, N., Dode, C., Chardenoux, S., Weissenbach, J., El Zir, E., Loiselet, J., Petit, C. Mapping of DFNB12, a gene for a non-syndromal autosomal recessive deafness, to chromosome 10q21-22. Hum. Mol. Genet., 1996, 5: 1061-1064.
216. Bork, J.M., Peters, L.M., Riazuddin, S., Bernstein, S.L., Ahmed, Z.M., Ness, S.L., Polomeno, R., Ramesh, A., Schloss, M., Srisailpathy, C.R., Wayne, S., Bellman, S., Desmukh, D., Ahmed, Z., Khan, S.N., Kaloustian, V.M., Li, X.C., Lalwani, A., Riazuddin, S., Bitner-Glindzicz, M., Nance, W.E., Liu, X.Z., Wistow, G., Smith, R.J., Griffith, A.J., Wilcox, E.R., Friedman, T.B., Morell, R.J. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am. J. Hum. Genet., 2001, 68: 26-37.
217. Alagramam, K.N., Murcia, C.L., Kwon, H.Y., Pawlowski, K.S., Wright, C.G., Woychik, R.P. The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat. Genet., 2001, 27: 99-102.
218. Alagramam, K.N., Yuan, H., Kuehn, M.H., Murcia, C.L., Wayne, S., Srisailpathy, C.R., Lowry, R.B., Knaus, R., Van Laer, L., Bernier, F.P., Schwartz, S., Lee, C., Morton, C.C., Mullins, R.F., Ramesh, A., Van Camp, G., Hagemen, G.S., Woychik, R.P., Smith, R.J. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum. Mol. Genet., 2001, 10: 1709-1718.
219. Ahmed, Z.M., Riazuddin, S., Bernstein, S.L., Ahmed, Z., Khan, S., Griffith, A.J., Morell, R.J., Friedman, T.B., Riazuddin, S., Wilcox, E.R. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am. J. Hum. Genet., 2001, 69: 25-34.
220. Van Camp, G., Coucke, P., Balemans, W., Van Velzen, D., van de, B.C., Van Laer, L., Smith, R.J., Fukushima, K., Padberg, G.W., Frants, R.R. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum. Mol. Genet., 1995, 4: 2159-2163.
221. Van Laer, L., Van Camp, G., van Zuijlen, D., Green, E.D., Verstreken, M., Schatteman, I., Van de, H.P., Balemans, W., Coucke, P., Greinwald, J.H., Smith, R.J., Huizing, E., Willems, P. Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Eur. J. Hum. Genet., 1997, 5: 397-405.
222. Van Laer, L., Huizing, E.H., Verstreken, M., van Zuijlen, D., Wauters, J.G., Bossuyt, P.J., Van de, H.P., McGuirt, W.T., Smith, R.J., Willems, P.J., Legan, P.K., Richardson, G.P., Van Camp, G. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat. Genet., 1998, 20: 194-197.
223. Yasunaga, S., Grati, M., Cohen-Salmon, M., El Amraoui, A., Mustapha, M., Salem, N., El Zir, E., Loiselet, J., Petit, C. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet., 1999, 21: 363-369.
224. Yasunaga, S., Grati, M., Chardenoux, S., Smith, T.N., Friedman, T.B., Lalwani, A.K., Wilcox, E.R., Petit, C. OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9. Am. J. Hum. Genet., 2000, 67: 591-600.
225. Mirghomizadeh, F., Pfister, M., Apaydin, F., Petit, C., Kupka, S., Pusch, C., Zenner, H.P., Blin, N. Substitutions in the conserved C2C domain of otoferlin, cause DFNB9, a form of non-syndromic autosomal recessive deafness. Neurobiolqy of Disease, 2002, 10: 157-164.
226. Verpy, E., Masmoudi, S., Zwaenepoel, I., Leibovici, M., Hutchin, T.P., Del, C. I., Nouaille, S., Blanchard, S., Laine, S., Popot, J.L., Moreno, F., Mueller, R.F., Petit, C. Mutations in a new gene encoding a protein of the hair bundle cause non- syndromic deafness at the DFNB16 locus. Nat. Genet., 2001, 29: 345-349.
227. Wise, C.A., Chiang, L.C., Paznekas, W.A., Sharma, M., Musy, M.M., Ashley, J.A., Lovett, M., Jabs, E.W. TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins Syndrome throughout its coding region. Proc. Natl. Acad. Sci. USA, 1997, 94: 3110-3115.
228. Dixon, J., Edwards, S.J., Anderson, I., Brass, A., Scambler, P.J., Dixon, M.J. Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene. Genome. Res., 1997, 7: 223-234.
229. Edwards, S.J., Gladwin, A.J., Dixon, M.J. The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am. J. Hum. Genet., 1997, 60: 515-524.
230. Splendore, A., Silva, E.O., Alonso, L.G., Richieri-Costa, A., Alonso, N., Rosa, A., Carakushanky, G., Cavalcanti, D.P., Brunoni, D., Passos-Bueno, M.R. High mutation detection rate in TCOF 1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum. Mutat., 2000, 16: 315-322.
231. Mohr, J. and Mageroy, K. Sex-linked deafness of a possibly new type. Acta. Genet. Statis. Med, 1960, 10: 54-62.
232. Tranebjaerg, L., Schwartz, C., Eriksen, H., Andreasson, S., Ponjavic, V., Dahl, A., Stevenson, R.E., May, M., Arena, F., Barker, D. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J. Med. Genet., 1995, 32: 257-263.
233. Jin, H., May, M., Tranebjaerg, L., Kendall, E., Fontan, G., Jackson, J., Subramony, S.H., Arena, F., Lubs, H., Smith, S., Stevenson, R., Schwartz, C., Vetrie, D. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat. Genet., 1996, 14: 177-180.
234. Koehler, C.M., Leuenberger, D., Merchant, S., Renold, A., Junne, T., Schatz, G. Human deafness dystonia syndrome is a mitochondrial disease. Proc. Natl. Acad. Sci. USA, 1999, 96: 2141-2146.
235. Kurima, K., Peters, L.M., Yang, Y., Riazuddin, S., Ahmed, Z.M., Naz, S., Arnaud, D., Drury, S., Mo, J., Makishima, T., Ghosh, M., Menon, P.S., Deshmukh, D., Oddoux, C., Ostrer, H., Khan, S., Riazuddin, S., Deininger, P.L., Hampton, L,L., Sullivan, S.L., Battey, J.F. Jr., Keats, B.J., Wilcox, E.R., Friedman, T.B., Griffith, A.J. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat. Genet., 2002, 30: 277-284.
236. Veske, A., Oehlmann, R., Younus, F., Mohyuddin, A., Muller-Myhsok, B., Mehdi, S.Q., Gal, A. Autosomal recessive non-syndromic deafness locus (DFNB8) maps on chromosome 21q22 in a large consanguineous kindred from Pakistan. Hum. Mol. Genet., 1996, 5: 165-168.
237. Bonne-Tamir, B., DeStefano, A.L., Briggs, C.E., Adair, R., Franklyn, B., Weiss, S., Korostishevsky, M., Frydman, M., Baldwin, C.T., Farrer, L.A. Linkage of congenital recessive deafness (gene DFNB10) to chromosome 21q22.3. Am. J. Hum. Genet., 1996, 58: 1254-1259.
238. Scott, H.S., Kudoh, J., Wattenhofer, M., Shibuya, K., Berry, A., Chrast, R., Guipponi, M., Wang, J., Kawasaki, K., Asakawa, S., Minoshima, S., Younus, F., Mehdi, S.Q., Radhakrishna, U., Papasavvas, M.P., Gehrig, C., Rossier, C., Korostishevsky, M., Gal, A., Shimizu, N., Bonne-Tamir, B., Antonarakis, S.E. Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat. Genet., 2001, 27: 59-63.
239. Joensuu, T., Hamalainen, R., Yuan, B., Johnson, C., Tegelberg, S., Gasparini, P., Zelante, L., Pirvola, U., Pakarinen, L., Lehesjoki, A.E., de la, C.A., Sankila. E.M. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am. J. Hum. Genet., 2001, 69: 673-684.
240. Strom, T.M., Hortnagel, K., Hofmann, S., Gekeler, F., Scharfe, C., Rabl, W., Gerbitz, K.D., Meitinger, T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet., 1998, 7: 2021-2028.
241. Khanim, F., Kirk, J., Latif, F., Barrett, T.G. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum. Mutat., 2001, 17: 357-367.
242. Bespalova, I.N., Van Camp, G., Bom, S.J., Brown, D.J., Cryns, K., DeWan, A.T., Erson, A.E., Flothmann, K.; Kunst, H.P., Kurnool, P., Sivakumaran, T.A., Cremers, C.W., Leal, S.M., Burmeister, M., Lesperance, M.M. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum. Mol. Genet., 2001, 10: 2501-2508.
243. Young, T.L., Ives, E., Lynch, E., Person, R., Snook, S., MacLaren, L., Cator, T., Griffin, A., Fernandez. B., Lee, M.K., King, M.C. Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum. Mol. Genet., 2001, 10: 2509-2514.
244. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P., Rogers, D., Mikuni, M., Kumashiro, H., Higashi, K., Sobue, G., Oka, Y., Permutt, M.A. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet., 1998, 20: 143-148.
245. Takeda, K., Inoue, H., Tanizawa, Y., Matsuzaki, Y., Oba, J., Watanabe, Y., Shinoda, k., Oka, Y. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum. Mol. Genet., 2001, 10: 477-484.
246. Riazuddin, S., Castelein, C.M., Ahmed, Z.M., Lalwani, A.K., Mastroianni, M.A., Naz, S., Smith, T.N., Liburd, N.A., Friedman, T.B., Griffith, A.J., Riazuddin, S., Wilcox, E.R. Dominant modifier DFNM1 suppresses recessive deafness DFNB26. Nat. Genet., 2000, 26: 431-434.
247. Hutchin, T.P., Thompson, K.R., Parker, M., Newton, V., Bitner-Glindzicz, M., Mueller, R.F. Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment. J.Med. Genet., 2001, 38: 229-231.
248. Hutchin, T.P. and Cortopassi, G.A. Mitochondrial defects and hearing loss. Cell Mol. Life Sci., 2000, 57: 1927-1937.
249. Tamagawa Y., Kitamura, K., Hagiwara, H., Ishida, T., Nishizawa, M., Saito, T., Iwamoto, Y. Audiologic findings in patients with a point mutation at nucleotide 3,243 of mitochondrial DNA. Ann. Otol. Rhinol. Laryngol., 1997, 106: 338-342.
250. de Vries, D., Ruitenbeek, W., Begeer, J., Smit, P., Bentlage, H., van Oost, B. Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. J. Neurol. Sci., 1994, 124: 77-82.
251. Goto, Y., Koga, Y., Horai, S., Nonaka, I. Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J. Neurol. Sci., 1990, 100: 63-69.
252. Shoffner, J.M. and Wallace, D.C. Heart disease and mitochondrial DNA mutations. Heart Dis. Stroke, 1992, 1: 235-241.
253. Moraes, C.T., Ciacci, F., Bonilla, E., Jansen, C., Hirano, M., Rao, N., Lovelace, R.E., Rowland, L.P., Schon, E.A., DiMauro, S. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J. Clin. Invest., 1993, 92: 2906-2915.
254. Ballinger, S.W., Shoffner, J.M., Hedaya, E.V., Trounce, I., Polak, M.A., Koontz, D.A., Wallace, D.C. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet., 1992, 1: 11-15.
255. Hao, H., Bonilla, E., Manfredi, G., DiMauro, S., Moraes, C.T. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am. J. Hum. Genet., 1995, 56: 1017-1025.
256. Ballinger, S.W., Shoffner, J.M., Hedaya, E.V., Trounce, I., Polak, M.A., Koontz, D.A., Wallace, D. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet., 1992, 1: 11-15.
257. Hao, H., Bonilla, E., Manfredi, G., DiMauro, S., Moraes, C.T. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am. J. Hum. Genet., 1995, 56: 1017-1025.
258. Moraes, C.T., DiMauro, S., Zeviani, M., Lombes, A., Shanske, S., Miranda, A.F., Nakase, H., Bonilla, E., Werneck, L.C., Servidei, S. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J. Med., 1989, 320: 1293-1299.
259. Hu, D.N., Qui, W.Q., Wu, B.T., Fang, L.Z., Zhou, F., Gu, Y.P., Zhang, Q.H. Yan, J.H., Ding, Y.Q., Wong, H. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J. Med. Genet., 1991, 28: 79-83.
260. Jaber, L., Shohat, M., Bu, X., Fischel-Ghodsian, N., Yang, H.Y., Wang, S.J., Rotter, J.I. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J. Med. Genet., 1992, 29: 86-90.
261. Bykhovskaya, Y., Shohat, M., Ehrenman, K., Johnson, D., Hamon, M., Cantor, R.M., Aouizerat, B., Bu, X., Rotter, J.I., Jaber, L., Fischel-Ghodsian, N. Evidence for complex nuclear inheritance in a pedigree with nonsyndromic deafness due to a homoplasmic mitochondrial mutation. Am. J. Med Genet., 1998, 77: 421-426.
262. Bykhovskaya, Y., Estivill, X., Taylor, K., Hang, T., Hamon, M., Casano, R.A., Yang, H., Rotter, J.I., Shohat, M., Fischel-Ghodsian, N. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am. J. Hum. Genet., 2000, 66: 1905-1910.
263. Bykhovskaya, Y., Yang, H., Taylor, K., Hang, T., Tun, R.Y., Estivill, X., Casano, R.A., Majamaa, K., Shohat, M., Fischel-Ghodsian, N. Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet. Med., 2001, 3: 177-180.
264. Prezant, T.R., Agapian, J.V., Bohlman, M.C., Bu, X., Oztas, S., Qiu, W.Q., Arnos, K.S., Cortopassi, G.A., Jaber, L., Rotter, J.I. Mitochondrial ribosomal RNA mutation associated with both antibiotic- induced and non-syndromic deafness. Nat. Genet., 1993, 4: 289-294.
265. Guan, M.X, Fischel-Ghodsian, N., Attardi, G. Biochemical evidence for nuclear gene involvement in phenotype of nonsyndromic deafness associated with mitochondrial 12S rRNA mutation. Hum. Mol. Genet., 1996, 5: 963-971.
266. Hutchin, T. Sensorineural hearing loss and the 1555G mitochondrial DNA mutation. Acta. Otolaryngol., 1999, 119: 48-52.
267. Fischel-Ghodsian, N., Prezant, T.R., Bu, X., Oztas, S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am. J. Otolaryngol., 1993, 14: 399-403.
268. Pandya, A., Xia, X., Radnaabazar, J., Batsuuri, J., Dangaansuren, B., Fischel-Ghodsian, N., Nance, W.E. Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J. Med. Genet., 1997, 34: 169-172.
269. Estivill, X., Govea, N., Barcelo, E., Badenas, C., Romero, E., Moral, L., Scozzri, R., D'Urbano, L., Zeviani, M., Torroni, A. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am. J. Hum. Genet., 1998, 62: 27-35.
270. Casano, R.A., Bykhovskaya, Y., Johnson, D.F., Hamon, M., Torricelli, F., Bigozzi, M., Fischel-Ghodsian, N. Hearing loss due to the mitochondrial A1555G mutation in Italian families. Am. J. Med. Genet., 1998, 79: 388-391.
271. Abe, S., Usami, S., Shinkawa, H., Weston, M.D., Overbeck, L.D., Hoover, D.M., Kenyon, J.B., Horai, S., Kimberling, W.J. Phylogenetic analysis of mitochondrial DNA in Japanese pedigrees of sensorineural hearing loss associated with the A1555G mutation. Eur. J. Hum. Genet., 1998. 6: 563-569.
272. Kupka, S., Toth, T., Wrobel, M., ZeiBler, U., Szyfter, W., Szyfter, K., Niedzielska, G., Bal, J., Zenner, H., Sziklai, I., Blin, N., Pfister, M. Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients. Hum. Mutat., 2002, 19: 308-309.
273. Hutchin, T. Sensorineural hearing loss and the 1555G mitochondrial DNA mutation. Acta Otolaryngol., 1999, 119: 48-52.
274. Fischel-Ghodsian, N., Prezant, T.R., Bu, X., Oztas, S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am. J. Otolaryngol., 1993, 14: 399-403.
275. Pandya, A., Xia, X., Radnaabazar, J., Batsuuri, J., Dangaansuren, B., Fischel-Ghodsian, N., Nance, W.E. Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J. Med. Genet., 1997, 34: 169-172.
276. Estivill, X., Govea, N., Barcelo, E., Badenas, C., Romero, E., Moral, L., Scozzri, R., D'Urbano, L., Zeviani. M., Torroni, A. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am. J. Hum. Genet., 1998, 62: 27-35.
277. Casano, R.A., Bykhovskaya, Y., Johnson, D.F., Hamon, M., Torricelli, F., Bigozzi, M., Fischel-Ghodsian, N: Hearing loss due to the mitochondrial A1555G mutation in Italian families. Am. J. Med. Genet., 1998, 79: 388-391.
278. Abe, S., Usami, S., Shinkawa, H., Weston, M.D., Overbeck, L.D., Hoover, D.M., Kenyon, J.B., Horai, S., Kimberling WJ: Phylogenetic analysis of mitochondrial DNA in Japanese pedigrees of sensorineural hearing loss associated with the A1555G mutation. Eur. J. Hum. Genet., 1998, 6: 563-569.
279. Kupka, S., Toth, T., Wrobel, M., ZeiBler, U., Szyfter, W., Szyfter, K., Niedzielska, G., Bal, J., Zenner, H., Sziklai, I., Blin, N., Pfister, M. Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients. Hum.Mutat. 2002, 19: 308-309.
280. Verhoeven, K., Ensink, R.J., Tiranti, V., Huygen, P.L., Johnson, D.F., Schatteman, I., Van Laer, L., Verstreken, M., Van de, H.P., Fischel-Ghodsian, N., Zeviani, M., Cremers, C.W., Willems, P.J., Van Camp, G. Hearing impairment and neurological dysfunction associated with a mutation in the mitochondrial tRNASer(UCN) gene. Eur. J. Hum. Genet., 1999, 7: 45-51.
281. Sue, C.M., Tanji, K., Hadjigeorgiou, G., Andreu, A.L., Nishino, I., Krishna, S., Bruno, C., Hirano, M., Shanske, S., Bonilla, E., Fischel-Ghodsian, N., DiMauro, S., Friedman, R. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology, 1999, 52: 1905-1908.
282. Hutchin, T.P., Parker, M.J., Young I.D., Davis. A.C., Pulleyn, L.J., Deeble, J., Lench, N.J., Markham AF. Mueller, R.F. A novel mutation in the mitochondrial tRNA(Ser(UCN)) gene in a family with non-syndromic sensorineural hearing impairment. J. Med. Genet., 2000, 37: 692-694.
283. Sue, C.M., Tanji, K., Hadjigeorgiou, G., Andreu, A.L., Nishino, I., Krishna, S., Bruno, C., Hirano, M., Shanske, S., Bonilla, E., Fischel-Ghodsian, N., DiMauro, S., Friedman, R. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology, 1999, 52: 1905-1908.
284. Hutchin, T.P., Parker, M.J., Young, I.D., Davis, A.C., Pulleyn, L.J., Deeble, J., Lench, N.J., Markham, A.F., Mueller, R.F. A novel mutation in the mitochondrial tRNA(Ser(UCN)) gene in a family with non-syndromic sensorineural hearing impairment. J. Med. Genet., 2000, 37: 692-694.